Iovance Biotherapeutics News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Iovance Biotherapeutics Inc IOVA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 30.75 04:01:54
Open Price Low Price High Price Close Price Prev Close
more quote information »

Recent News

Date Time Source Heading
4/16/202109:53SEEKPPD cut following Thermo Scientific deal, Apellis and..
4/16/202108:21SEEKIOVA, LSCC, WIT and GSX among premarket gainers
4/12/202109:45TRMNIovance Gives Clinical Data Update For Melanoma Drug
4/09/202107:56SEEKIovance Bio reports lifileucel data in advanced melanoma at..
4/09/202107:00GLOBEIovance Biotherapeutics Announces Clinical Data Updates for..
3/15/202116:12EDGARCurrent Report Filing (8-k)
3/15/202116:05SEEKIovance Biotherapeutics names Igor Bilinsky chief operating..
3/15/202116:01GLOBEIovance Biotherapeutics Appoints Igor Bilinsky as Chief..
3/12/202117:16EDGARCurrent Report Filing (8-k)
3/11/202116:31EDGARCurrent Report Filing (8-k)
3/10/202117:28GLOBEIovance Biotherapeutics to Present Updated Clinical Data for..
3/01/202116:01GLOBEIovance Biotherapeutics to Present at Upcoming Healthcare..
2/25/202117:36SEEKIovance shares close more than 7% down while Q4 2020 results..
2/25/202116:06EDGARCurrent Report Filing (8-k)
2/25/202116:05SEEKIovance Biotherapeutics EPS misses by $0.03
2/25/202116:01GLOBEIovance Biotherapeutics Reports Fourth Quarter and Full Year..
2/24/202117:35SEEKIovance Biotherapeutics Q4 2020 Earnings Preview
2/18/202107:30GLOBEIovance Biotherapeutics to Host Fourth Quarter and Full Year..
2/16/202115:34EDGARAmended Statement of Ownership (sc 13g/a)
2/16/202112:27EDGARAmended Statement of Ownership (sc 13g/a)
2/12/202108:04EDGARAmended Statement of Ownership (sc 13g/a)
2/10/202111:22EDGARAmended Statement of Ownership (sc 13g/a)
2/09/202106:46EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/09/202106:08EDGARCurrent Report Filing (8-k)
2/09/202106:06EDGARCurrent Report Filing (8-k)
1/29/202110:05EDGARAmended Statement of Ownership (sc 13g/a)
1/19/202108:56GLOBEIovance Biotherapeutics to Present at Upcoming Healthcare..
1/11/202114:22EDGARStatement of Ownership (sc 13g)
1/06/202117:02EDGARStatement of Changes in Beneficial Ownership (4)
1/06/202117:02EDGARStatement of Changes in Beneficial Ownership (4)
1/06/202117:01EDGARStatement of Changes in Beneficial Ownership (4)
12/28/202007:30GLOBEIovance Biotherapeutics to Present at the 39th Annual J.P...
12/14/202017:16EDGARCurrent Report Filing (8-k)
12/14/202007:00GLOBEIovance Biotherapeutics Appoints Jean-Marc Bellemin as Chief..
11/30/202007:21GLOBEIovance Biotherapeutics to Present at Upcoming Conferences..
11/09/202008:00GLOBEIovance Biotherapeutics Presents Clinical Data in Head and..
11/05/202016:07EDGARCurrent Report Filing (8-k)
11/05/202016:00GLOBEIovance Biotherapeutics Reports Third Quarter and..
10/30/202007:00GLOBEIovance Biotherapeutics to Host Third Quarter 2020 Financial..
10/28/202007:45GLOBEIovance Biotherapeutics to Present at Upcoming Conferences..
10/14/202017:07EDGARCurrent Report Filing (8-k)
10/14/202017:01GLOBEIovance Biotherapeutics to Present Clinical Data in Head and..
10/06/202007:00GLOBEIovance Biotherapeutics to Present at Upcoming October..
10/05/202017:17EDGARCurrent Report Filing (8-k)
10/05/202016:01GLOBEIovance Biotherapeutics Provides Update for Lifileucel in..
8/07/202007:30GLOBEIovance Biotherapeutics to Present at BTIG Biotechnology..
8/06/202017:19EDGARQuarterly Report (10-q)
8/06/202016:06EDGARCurrent Report Filing (8-k)
8/06/202016:01GLOBEIovance Biotherapeutics Reports Second Quarter 2020..
8/06/202008:05GLOBEAvid Bioservices Selected By Iovance Biotherapeutics to Lead..
See more news about this stock »

Your Recent History
Iovance Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.